Call Us + 33 1 84 88 31 00

Article R5139-30 of the French Public Health Code

I.- Veterinary proprietary medicinal products and auto-vaccines for veterinary use containing micro-organisms or toxins are prescribed under the conditions mentioned in I, III and IV of article R. 5141-111. A prescription may not be made for a treatment period exceeding twelve months. II – Veterinary medicinal products and auto-vaccines for veterinary use containing micro-organisms or toxins are dispensed under the conditions set out in articles R. 5132-6 and R. 5132-7…

Read More »

Article R5139-31 of the French Public Health Code

Persons authorised to supply proprietary medicinal products for human use, proprietary veterinary medicinal products, investigational medicinal products for human use or auto-vaccines for veterinary use containing micro-organisms or toxins must transcribe all entries and withdrawals in a register or record them on a specific computer system meeting the following conditions: 1° It must not be possible to modify the data once it has been validated; 2° It must be possible…

Read More »

Article R513-10-1 of the French Public Health Code

Tattoo products are rendered sterile using appropriate processes. They are supplied in a container which retains sterility until use. Multiple dose containers are authorised provided that the delivery of each dose does not compromise the sterility of the product remaining in the container, a dose being defined as the quantity of product used for a single person during a single session. The quality of the colouring substances complies with that…

Read More »

Article R513-10-2 of the French Public Health Code

The declaration provided for in Article L. 513-10-2 shall be sent by any means giving a date certain to the Agence nationale de sécurité du médicament et des produits de santé. It shall indicate 1° The name or corporate name, address and legal nature of the company to which the establishment belongs ; 2° The address of the establishment in France and the exact nature of the planned activity; 3°…

Read More »

Article R513-10-3 of the French Public Health Code

The person responsible for placing a tattoo product on the market, established in France, shall make the file provided for in the third paragraph of article L. 513-10-5 available to the supervisory authorities at the address given in 6° of article R. 513-10-5. This file includes : 1° The qualitative and quantitative formula of the product ; 2° The physico-chemical and microbiological specifications of the raw materials and the tattoo…

Read More »

Article R513-10-4 of the French Public Health Code

The following are laid down by order of the Minister for Health, on a proposal from the Director General of the Agence nationale de sécurité du médicament et des produits de santé: 1° The list of substances that may not be used in tattooing products; 2° The list of substances that may not be used in tattooing products, unless they comply with the restrictions and conditions set out in this…

Read More »

Article R513-10-5 of the French Public Health Code

Without prejudice to the information required by other legislative or regulatory provisions, the container and packaging of each unit of tattooing product placed on the market free of charge or against payment must include the following information, written in such a way as to be legible, comprehensible and indelible: 1° The name of the product ; 2° The nominal content at the time of packaging, indicated by mass or volume;…

Read More »

Article R513-10-6 of the French Public Health Code

For the purposes of this section, : “Misuse”: use that does not comply with the intended purpose of the product, its usual use or its instructions for use, or with the special precautions for use mentioned in 7° of article R. 513-10-5; Adverse reaction”: a noxious and unintended response occurring under normal conditions of use of a tattooing product or resulting from misuse of such a product; “Serious adverse reaction”:…

Read More »

Article R513-10-7 of the French Public Health Code

Tattoo products are subject to vigilance designed to monitor undesirable effects occurring under normal conditions of use of the product or resulting from misuse. This vigilance is applied to all these products once they have been placed on the market.

Read More »

Article R513-10-8 of the French Public Health Code

The national vigilance system comprises : 1° The Agence nationale de sécurité du médicament et des produits de santé ; 2° The competent administrative authorities designated in accordance with the procedures set out inArticle L. 221-1-3 of the French Consumer Code; 3° Health professionals; 4° The person responsible for placing a tattoo product on the market; 5° Persons who carry out tattooing on a professional basis; 6° Consumers of tattoo…

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.